{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:21:42Z","timestamp":1766546502363,"version":"3.48.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008463","name":"Airlangga University","doi-asserted-by":"publisher","award":["1064\/UN3.14\/PT\/2020"],"award-info":[{"award-number":["1064\/UN3.14\/PT\/2020"]}],"id":[{"id":"10.13039\/501100008463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127571","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:44:40Z","timestamp":1754441080000},"page":"127571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Memory T cell reactivity to a broad range of conserved SARS-CoV-2-derived ORF1ab epitopes in first wave COVID-19 convalescents"],"prefix":"10.1016","volume":"62","author":[{"given":"Fadhil","family":"Ahsan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanda Yuli","family":"Rahmawati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erry Gumilar","family":"Dachlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fidyah Nanda","family":"Alditia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Budi","family":"Santoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6529","key":"10.1016\/j.vaccine.2025.127571_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127571_bb0010","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/vaccines11071186","article-title":"SARS-CoV-2 T cell immunity responses following natural infection and vaccination","volume":"11","author":"Pitiriga","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127571_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127571_bb0020","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127571_bb0025","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127571_bb0030","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127571_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109708","article-title":"Profiling CD8+ T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants","volume":"36","author":"Zhang","year":"2021","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127571_bb0040","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/v13060972","article-title":"Identification of novel candidate CD8+ T cell epitopes of the SARS-CoV-2 with homology to other seasonal coronaviruses","volume":"13","author":"Pushpakumara","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127571_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127571_bb0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fcimb.2019.00344","article-title":"The quest for a truly universal influenza vaccine","author":"Jang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127571_bb0055","article-title":"Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells","volume":"2","author":"Cohen","year":"2021","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127571_bb0060","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/biomedicines12030564","article-title":"The influence of cross-reactive T cells in COVID-19","volume":"12","author":"Eggenhuizen","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127571_bb0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127571_bb0070","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/vaccines9121459","article-title":"Immunoinformatics analysis of SARS-CoV-2 ORF1ab polyproteins to identify promiscuous and highly conserved T-cell epitopes to formulate vaccine for Indonesia and the world population","volume":"9","author":"Gustiananda","year":"2021","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127571_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12967-023-03996-w","article-title":"Global landscape of SARS-CoV-2 mutations and conserved regions","volume":"21","author":"Abbasian","year":"2023","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127571_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s13205-021-02749-0","article-title":"A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing","volume":"11","author":"Kumar","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.vaccine.2025.127571_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199392","article-title":"A systematic mutation analysis of 13 major SARS-CoV-2 variants","volume":"345","author":"Bai","year":"2024","journal-title":"Virus Res"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127571_bb0090","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20161760","article-title":"Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis","volume":"214","author":"Abdelsamed","year":"2017","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127571_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134251","article-title":"Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis","volume":"5","author":"Wu","year":"2020","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127571_bb0100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41577-021-00625-9","article-title":"T cell-oriented strategies for controlling the COVID-19 pandemic","volume":"21","author":"Noh","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127571_bb0105","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.chom.2021.05.010","article-title":"SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19","volume":"29","author":"Grifoni","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127571_bb0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00251-021-01250-5","article-title":"Immunoinformatics prediction of potential immunodominant epitopes from human coronaviruses and association with autoimmunity","volume":"74","author":"Mathew","year":"2022","journal-title":"Immunogenetics"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127571_bb0115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/cells10040821","article-title":"Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19","volume":"10","author":"Yadav","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127571_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000468","article-title":"T cell immune memory after COVID-19 and vaccination","volume":"2","author":"Wang","year":"2023","journal-title":"BMJ Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127571_bb0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127571_bb0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41577-022-00809-x","article-title":"The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses","volume":"23","author":"Murray","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127571_bb0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41541-024-00957-2","article-title":"Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants","volume":"9","author":"Hajnik","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127571_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155789","article-title":"A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies","volume":"9","author":"Shi","year":"2024","journal-title":"JCI Insight"},{"issue":"10280","key":"10.1016\/j.vaccine.2025.127571_bb0145","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(21)00662-0","article-title":"Risk of SARS-CoV-2 reinfection after natural infection","volume":"397","author":"Boyton","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127571_bb0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12964-022-00856-w","article-title":"A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)","volume":"20","author":"Mohammed","year":"2022","journal-title":"Cell Commun Signal"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127571_bb0155","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12250-021-00348-0","article-title":"Alterations in phenotypes and responses of T cells within 6 months of recovery from COVID-19: a cohort study","volume":"36","author":"Zhao","year":"2021","journal-title":"Virol Sin"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127571_bb0160","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"1","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127571_bb0165","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.3390\/jcm12103539","article-title":"Persistent exhausted T-cell immunity after severe COVID-19: 6-month evaluation in a prospective observational study","volume":"12","author":"Vazquez-Alejo","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127571_bb0170","article-title":"Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127571_bb0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/sji.12329","article-title":"Clinical role of human leukocyte antigen in health and disease","volume":"82","author":"Mosaad","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2025.127571_bb0180","article-title":"SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire","volume":"18;5(6):101583","author":"Tarke","year":"2024","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127571_bb0185","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/vaccines11030545","article-title":"Significance of conserved regions in coronavirus spike protein for developing a novel vaccine against SARS-CoV-2 infection","volume":"11","author":"Olukitibi","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127571_bb0190","doi-asserted-by":"crossref","first-page":"1346349","DOI":"10.3389\/fcimb.2024.1346349","article-title":"A novel approach to designing viral precision vaccines applied to SARS-CoV-2","volume":"2","author":"Trabelsi","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127571_bb0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.chom.2023.12.003","article-title":"Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant","volume":"32","author":"Nesamari","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127571_bb0200","doi-asserted-by":"crossref","first-page":"1160065","DOI":"10.3389\/fimmu.2023.1160065","article-title":"Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2\/COVID-19 vaccine candidate","volume":"19","author":"Perdiguero","year":"2023","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:19:06Z","timestamp":1766546346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25008680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"alternative-id":["S0264410X25008680"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127571","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Memory T cell reactivity to a broad range of conserved SARS-CoV-2-derived ORF1ab epitopes in first wave COVID-19 convalescents","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127571"}}